Short description
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
London, England, United Kingdom, Europe
Founded on
January 1, 2020
Non-profit?
No
Acquired?
No
Employees count
11-50
Investors
Cannot Access, Noaccess, Cannot Access
Sign in for full access
Founders
Diana Kraskouskaya, Patrick T. Gunning